text: Yo, check it out, let me break it down for you real quick
  We studied 25 patients with heart failure, that's the trick
  Ischemic or myopathic, it's a tough situation
  Group I, clinically unstable, facing severe devastation
  
  Group II, stable but mild to moderate stress
  Monitoring their VO2 max, the ultimate test
  With oral and IV piroximone, we made a move
  Significantly improving ventricular pump function, smooth groove
  
  Heart rate stayed steady, no drop in arterial pressure
  No acute changes in myocardial O2 uptake, I must measure
  No lactate production, everything was clean
  Oral piroximone held its benefits for five hours, mean
  
  No tolerance observed, even with the third and fourth doses
  In Group II, VO2 max increased, man, that's the prognosis
  At 4, 8, 12, 24, and 48 weeks, it showed the power
  Piroximone therapy, making hearts stronger by the hour
  
  But hold up, a couple of patients faced some strife
  Gastrointestinal issues, causing some real-life
  And one had supraventricular tachycardia, true
  So we need controlled trials to see what piroximone can do
  
  In the long-term management of chronic heart failure, that's the goal
  We gotta determine efficacy and safety, let's take control
  So let's undertake those clinical trials, make it official
  Piroximone might just be the key, we're being beneficial